ribavirin has been researched along with Retinal Diseases in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 14 (60.87) | 29.6817 |
| 2010's | 8 (34.78) | 24.3611 |
| 2020's | 1 (4.35) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, JC; Muo, CH; Su, FH; Wu, CM; Wu, MM; Yeh, CC | 1 |
| Chen, PC; King, YC; Lai, CH; Liu, CY; Yang, YH | 1 |
| Inao, M; Mochida, S; Nakayama, N; Sugawara, K | 1 |
| Abruzzese, G; Alpert, S; Kaul, V; Mehta, N; Murthy, UK; Teitelbaum, C | 1 |
| Gilani, N; Panetta, JD | 1 |
| Bacin, F; Glatre, F; Viennet, A | 1 |
| Chin, HS; Kim, ET; Kim, LH; Lee, JI | 1 |
| Hara, K; Ohira, A; Tanito, M | 1 |
| Burgueño-Montañés, C; Pérez-Álvarez, R | 1 |
| Goldenberg, D; Kurtz, S; Moisseiev, E | 1 |
| Fouad, YM; Helmy, AK; Ibraheem, H; Khalaf, H; Rady, H | 1 |
| Abdel-Aziz, A; Besheer, T; Elbendary, A; Gad, Y; Mokbel, T; Mousa, N | 1 |
| King, J; Kooragayala, LM; Liang, C; Schulman, JA | 1 |
| Tsolakos, A; Zalatimo, N | 1 |
| Crochet, M; Dupuy, P; Even, G; Ingster-Moati, I | 1 |
| Cuthbertson, FM; Davies, M; McKibbin, M | 1 |
| Arruga-Ginebreda, J; Castillo-Campillo, L; Mesa-Toledo, E; Miserachs-García, S | 1 |
| Kimu, M; Koike, N; Mitsutaka, M; Nakamura, T; Soda, M; Takahashi, H | 1 |
| Iino, S; Itoh, F; Kobayashi, Y; Koike, K; Nagase, Y; Okuse, C; Suzuki, M; Yasuda, K; Yotsuyanagi, H | 1 |
| Andrade, RJ; Camargo, R; Cilvetti, A; Clavijo, E; García-Cortés, M; González, FJ; Lucena, MI; Martos-VanDussen, JV; Rosón, P; Vázquez, L | 1 |
| Bader, P; Bourcier, T; Lenoble, P; Nasica, X; Sauer, A; Speeg-Schatz, C | 1 |
| Feroze, AH; Hamid, K; Khan, H | 1 |
| Heathcote, J; Jain, K; Lam, WC; Thai, Q; Waheeb, S | 1 |
1 review(s) available for ribavirin and Retinal Diseases
| Article | Year |
|---|---|
[Retinopathy caused by interferon alpha associated with ribavirin therapy and the importance of the electro-oculogram: a case report].
Topics: Adult; Antiviral Agents; Electrooculography; Female; Humans; Interferon-alpha; Retinal Diseases; Ribavirin | 2004 |
2 trial(s) available for ribavirin and Retinal Diseases
| Article | Year |
|---|---|
Risk factors for retinopathy associated with interferon alpha-2b and ribavirin combination therapy in patients with chronic hepatitis C.
Topics: Adult; Aged; Antiviral Agents; Drug Therapy, Combination; Female; Fundus Oculi; Hepatitis C, Chronic; Humans; Hypertension; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Prevalence; Prospective Studies; Recombinant Proteins; Regression Analysis; Retinal Diseases; Retinal Hemorrhage; Ribavirin; Risk Factors; Time Factors | 2006 |
Vascular ophthalmological side effects associated with antiviral therapy for chronic hepatitis C are related to vascular endothelial growth factor levels.
Topics: Adult; Aged; Antiviral Agents; Drug Therapy, Combination; Eye Diseases; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Retinal Diseases; Retinal Neovascularization; Ribavirin; Vascular Endothelial Growth Factor A | 2006 |
20 other study(ies) available for ribavirin and Retinal Diseases
| Article | Year |
|---|---|
Analysis of Different Types of Interferon-Associated Retinopathy in Patients with Chronic Hepatitis C Virus Infection Treated with Pegylated Interferon Plus Ribavirin.
Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Incidence; Interferon-alpha; Male; Middle Aged; Retinal Diseases; Retrospective Studies; Ribavirin | 2021 |
Retinal vascular complications associated with interferon-ribavirin therapy for chronic hepatitis C: A population-based study.
Topics: Adult; Antiviral Agents; Comorbidity; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Hypertension; Incidence; Interferon-alpha; Male; Middle Aged; Retina; Retinal Diseases; Retinal Vessels; Retrospective Studies; Ribavirin; Risk Factors; Taiwan | 2018 |
Telaprevir-induced, but not pegylated interferon-associated, retinopathy as a noteworthy adverse effect during triple antiviral therapy in patients with chronic hepatitis C.
Topics: Aged; Anemia; Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Interferons; Interleukins; Male; Middle Aged; Oligopeptides; Polyethylene Glycols; Polymorphism, Single Nucleotide; Recombinant Proteins; Retinal Diseases; Ribavirin | 2014 |
Outcome of retinopathy in chronic hepatitis C patients treated with peginterferon and ribavirin.
Topics: Antiviral Agents; Drug Carriers; Female; Follow-Up Studies; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Retinal Diseases; Ribavirin; Treatment Outcome | 2010 |
Interferon-induced retinopathy and its risk in patients with diabetes and hypertension undergoing treatment for chronic hepatitis C virus infection.
Topics: Adult; Aged; Antiviral Agents; Diabetes Mellitus; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Hypertension; Interferon alpha-2; Interferon-alpha; Interferons; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Retinal Diseases; Retrospective Studies; Ribavirin; Risk Factors | 2009 |
[Interferon-related retinopathy in a man with chronic hepatitis C].
Topics: Antiviral Agents; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Recombinant Proteins; Retinal Diseases; Ribavirin | 2009 |
Retinopathy in hepatitis C patients due to combination therapy with pegylated interferon and ribavirin.
Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Female; Fluorescein Angiography; Hepatitis C, Chronic; Humans; Hypertension; Incidence; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Retinal Diseases; Ribavirin; Risk Factors; Visual Acuity | 2009 |
Retinal nerve fibre layer defects associated with cotton-wool spots in patients with interferon retinopathy.
Topics: Aged; Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Intraocular Pressure; Middle Aged; Nerve Fibers; Polyethylene Glycols; Recombinant Proteins; Retinal Diseases; Retinal Ganglion Cells; Ribavirin; Tomography, Optical Coherence; Visual Acuity; Visual Fields | 2012 |
[Pegylated interferon and ribavirin associated retinopathy in patients with hepatitis C].
Topics: Adult; Aged; Antiviral Agents; Exudates and Transudates; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Polyethylene Glycols; Recombinant Proteins; Retinal Diseases; Retinal Hemorrhage; Ribavirin | 2011 |
Retinopathy associated with pegylated interferon and ribavirin causing permanent visual impairment in a patient with chronic hepatitis C.
Topics: Aged; Antiviral Agents; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Interferons; Male; Retinal Diseases; Ribavirin; Vision Disorders; Visual Acuity | 2011 |
Incidence and risk factors of retinopathy in Egyptian patients with chronic hepatitis C virus treated with pegylated interferon plus ribavirin.
Topics: Adult; Antiviral Agents; Egypt; Female; Follow-Up Studies; Hepacivirus; Hepatitis C, Chronic; Humans; Incidence; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Prospective Studies; Retinal Diseases; Retrospective Studies; Ribavirin; Risk Factors; Young Adult | 2012 |
Is combination therapy interferon and ribavirin in patients with chronic hepatitis C infection toxic for eyes?
Topics: Adult; Antiviral Agents; Diabetes Mellitus; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis C, Chronic; Humans; Hypertension; Interferon alpha-2; Interferon-alpha; Logistic Models; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Retinal Diseases; Ribavirin; Risk Factors | 2013 |
Posterior segment complications in patients with hepatitis C treated with interferon and ribavirin.
Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Female; Fluorescein Angiography; Hepatitis C, Chronic; Humans; Incidence; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Prospective Studies; Recombinant Proteins; Retina; Retinal Diseases; Ribavirin; Vision Disorders; Visual Fields | 2003 |
Hepatitis C: a review of diagnosis, management, and ocular complications from treatment.
Topics: Antiviral Agents; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Retinal Diseases; Ribavirin | 2003 |
Is screening for interferon retinopathy in hepatitis C justified?
Topics: Adult; Aged; Antiviral Agents; Diabetic Retinopathy; Drug Therapy, Combination; Female; Fluorescein Angiography; Hepatitis C; Humans; Interferon-alpha; Male; Middle Aged; Remission, Spontaneous; Retinal Diseases; Retinal Hemorrhage; Ribavirin | 2004 |
[Ischemic neuroretinopathy associated with use of interferon].
Topics: Antiviral Agents; Drug Therapy, Combination; Fluorescein Angiography; Follow-Up Studies; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Optic Neuropathy, Ischemic; Polyethylene Glycols; Recombinant Proteins; Retinal Diseases; Ribavirin; Time Factors; Visual Acuity; Visual Field Tests | 2005 |
[Retinopathy during interferon treatment in combination with ribavirin for chronic hepatitis C].
Topics: Aged; Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Recombinant Proteins; Retinal Diseases; Retinal Hemorrhage; Ribavirin | 2005 |
[Ocular complications of hepatitis C treatment].
Topics: Antiviral Agents; Hepatitis C; Humans; Interferon-alpha; Male; Middle Aged; Optic Nerve Diseases; Retinal Diseases; Ribavirin | 2007 |
Interferon associated retinopathy.
Topics: Adult; Antiviral Agents; Humans; Interferons; Male; Optic Nerve; Retinal Diseases; Ribavirin; Risk Factors | 2008 |
Retinopathy in chronic hepatitis C patients during interferon treatment with ribavirin.
Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Prospective Studies; Recombinant Proteins; Remission, Spontaneous; Retinal Diseases; Retinal Hemorrhage; Ribavirin; Treatment Outcome | 2001 |